Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | MMP2 | P08253 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | GFER | P55789 | 1/20 | 0.30 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.30 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4991691 | 0.91 | — | — | |
| SCHEMBL2691981 | 0.80 | TSHR (0.32) | TSHRNPSR1CA12CA1CA2 | |
| SCHEMBL696980 | 0.78 | ALDH1A1 (0.44) | TSHRNPSR1ALDH1A1THRB | |
| SCHEMBL698468 | 0.76 | ALDH1A1 (0.43) | TSHRNPSR1ALDH1A1THRB | |
| SCHEMBL4200003 | 0.76 | TSHR (0.38) | TSHRALDH1A1GRIK1 | |
| SCHEMBL2900646 | 0.76 | CES2 (0.33) | TSHRNPSR1SMN1; SMN2ALDH1A1EPHX2 | |
| SCHEMBL2191890 | 0.75 | EPHX1 (0.41) | CA12CA1CA2CA9SMN1; SMN2 | |
| SCHEMBL2908887 | 0.75 | TSHR (0.36) | TSHRCA12CA1CA2MMP2 | |
| SCHEMBL698515 | 0.74 | ALDH1A1 (0.44) | NPSR1ALDH1A1THRB | |
| SCHEMBL2906496 | 0.74 | HCAR2 (0.34) | ALDH1A1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0437016-A2 | Lipid A analogues having immunoactivating and anti-tumour activity | Sankyo Company Limited (JP) | 1991-07-17 | — | — | EP | disclosed |
| EP-0363223-A2 | 3-Aryloxymethyl-cephalosporin derivatives, their preparation and their medical use | Sankyo Company Limited (JP) | 1990-04-11 | — | — | EP | disclosed |